Renal Thermal Ablative Therapy

Samuel P. Sterrett, Stephen Y. Nakada, Marshall S. Wingo, Steve K. Williams, Raymond J. Leveillee

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Energy targeting is greatly enhanced through imaging modalities, which greatly assist needle placement or energy delivery to the optimal location for maximal effectiveness. When vital structures obscure access to the renal lesion, laparoscopic mobilization of these structures with direct visualization of the tumor can increase the likelihood of ablation success and minimize complication risk. Ablative therapies are attractive because of their minimal impact on patient quality of life in addition to their morbidity and cost. Although they show promise of efficacy, they must be evaluated with long-term follow-up before they are considered the standard of oncologic care. Renal masses can be treated with a laparoscopic or percutaneous approach depending on tumor location, size, and the available technology and experience of the center.

Original languageEnglish
Pages (from-to)397-414
Number of pages18
JournalUrologic Clinics of North America
Volume35
Issue number3
DOIs
StatePublished - Aug 1 2008
Externally publishedYes

Fingerprint

Hot Temperature
Kidney
Standard of Care
Needles
Neoplasms
Quality of Life
Technology
Morbidity
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Sterrett, S. P., Nakada, S. Y., Wingo, M. S., Williams, S. K., & Leveillee, R. J. (2008). Renal Thermal Ablative Therapy. Urologic Clinics of North America, 35(3), 397-414. https://doi.org/10.1016/j.ucl.2008.05.005

Renal Thermal Ablative Therapy. / Sterrett, Samuel P.; Nakada, Stephen Y.; Wingo, Marshall S.; Williams, Steve K.; Leveillee, Raymond J.

In: Urologic Clinics of North America, Vol. 35, No. 3, 01.08.2008, p. 397-414.

Research output: Contribution to journalArticle

Sterrett, SP, Nakada, SY, Wingo, MS, Williams, SK & Leveillee, RJ 2008, 'Renal Thermal Ablative Therapy', Urologic Clinics of North America, vol. 35, no. 3, pp. 397-414. https://doi.org/10.1016/j.ucl.2008.05.005
Sterrett SP, Nakada SY, Wingo MS, Williams SK, Leveillee RJ. Renal Thermal Ablative Therapy. Urologic Clinics of North America. 2008 Aug 1;35(3):397-414. https://doi.org/10.1016/j.ucl.2008.05.005
Sterrett, Samuel P. ; Nakada, Stephen Y. ; Wingo, Marshall S. ; Williams, Steve K. ; Leveillee, Raymond J. / Renal Thermal Ablative Therapy. In: Urologic Clinics of North America. 2008 ; Vol. 35, No. 3. pp. 397-414.
@article{7fc1f4a4075a470286d6cac9a8ae0bb1,
title = "Renal Thermal Ablative Therapy",
abstract = "Energy targeting is greatly enhanced through imaging modalities, which greatly assist needle placement or energy delivery to the optimal location for maximal effectiveness. When vital structures obscure access to the renal lesion, laparoscopic mobilization of these structures with direct visualization of the tumor can increase the likelihood of ablation success and minimize complication risk. Ablative therapies are attractive because of their minimal impact on patient quality of life in addition to their morbidity and cost. Although they show promise of efficacy, they must be evaluated with long-term follow-up before they are considered the standard of oncologic care. Renal masses can be treated with a laparoscopic or percutaneous approach depending on tumor location, size, and the available technology and experience of the center.",
author = "Sterrett, {Samuel P.} and Nakada, {Stephen Y.} and Wingo, {Marshall S.} and Williams, {Steve K.} and Leveillee, {Raymond J.}",
year = "2008",
month = "8",
day = "1",
doi = "10.1016/j.ucl.2008.05.005",
language = "English",
volume = "35",
pages = "397--414",
journal = "Urologic Clinics of North America",
issn = "0094-0143",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Renal Thermal Ablative Therapy

AU - Sterrett, Samuel P.

AU - Nakada, Stephen Y.

AU - Wingo, Marshall S.

AU - Williams, Steve K.

AU - Leveillee, Raymond J.

PY - 2008/8/1

Y1 - 2008/8/1

N2 - Energy targeting is greatly enhanced through imaging modalities, which greatly assist needle placement or energy delivery to the optimal location for maximal effectiveness. When vital structures obscure access to the renal lesion, laparoscopic mobilization of these structures with direct visualization of the tumor can increase the likelihood of ablation success and minimize complication risk. Ablative therapies are attractive because of their minimal impact on patient quality of life in addition to their morbidity and cost. Although they show promise of efficacy, they must be evaluated with long-term follow-up before they are considered the standard of oncologic care. Renal masses can be treated with a laparoscopic or percutaneous approach depending on tumor location, size, and the available technology and experience of the center.

AB - Energy targeting is greatly enhanced through imaging modalities, which greatly assist needle placement or energy delivery to the optimal location for maximal effectiveness. When vital structures obscure access to the renal lesion, laparoscopic mobilization of these structures with direct visualization of the tumor can increase the likelihood of ablation success and minimize complication risk. Ablative therapies are attractive because of their minimal impact on patient quality of life in addition to their morbidity and cost. Although they show promise of efficacy, they must be evaluated with long-term follow-up before they are considered the standard of oncologic care. Renal masses can be treated with a laparoscopic or percutaneous approach depending on tumor location, size, and the available technology and experience of the center.

UR - http://www.scopus.com/inward/record.url?scp=50349099342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50349099342&partnerID=8YFLogxK

U2 - 10.1016/j.ucl.2008.05.005

DO - 10.1016/j.ucl.2008.05.005

M3 - Article

C2 - 18761195

AN - SCOPUS:50349099342

VL - 35

SP - 397

EP - 414

JO - Urologic Clinics of North America

JF - Urologic Clinics of North America

SN - 0094-0143

IS - 3

ER -